NCT04127214

Brief Summary

This is a naturalistic study implementing a routine assessment to monitor the evolution of the patients with eating disorders being treated in various centers of "ITA salud mental" in Spain.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

8 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2017

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 1, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 15, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

8 years

First QC Date

October 1, 2019

Last Update Submit

March 30, 2025

Conditions

Keywords

eating disordersanorexia nervosabulimia nervosabinge eatingroutine outcome monitoringpsychological interventionsintegrated treatmenteffectiveness

Outcome Measures

Primary Outcomes (2)

  • Change in Clinical outcomes in routine evaluation outcome measure (CORE-OM)

    CORE-OM is a 34-item self-report questionnaire for the assessment of subjective well-being, symptoms or problems, life functioning, and risk. It has good psychometric properties and it has been validated for the Spanish population. Its transdiagnostic nature makes it suitable for all kinds of eating disorders especially if we take into account the frequent comorbidities with other mental disorders (e.g., depression, anxiety) of these patients. Short forms of this questionnaire (versions A and B) are used to monitor patients' progress.

    CORE-OM is administered at baseline, at one week, and then routinely every three months (using A and B short forms alternatively every three weeks until October 30th, 2020) until study completion.

  • Change in Eating Attitudes Test (EAT)

    The EAT (children and adult versions) is a 26-item standardized self-report questionnaire devised to measure symptoms and concerns characteristic of eating disorders. Although the EAT has been used as a screening tool, here it is used to gauge symptom severity. It has good psychometric properties and it has been validated for the Spanish population.

    EAT is administered at baseline, at one week, and then routinely every three months until study completion.

Secondary Outcomes (2)

  • Change in Bulimic Investigatory Test, Edinburgh (BITE)

    BITE is administered at baseline, at one week, and then routinely every three months until 30th. of October, 2020.

  • Change in Body Mass Index (BMI)

    Patients' weight and height is recorded at baseline and then weight every month (every thee-months after October 30th, 2020) up to 5 years. No follow-up data will be collected for this measure.

Interventions

The ITA Model combines outpatient intervention (mainly psychotherapy), day hospital care and hospitalization as a function of patients' characteristics. Case conceptualization of the psychological processes of patients is formulated and revised within a team including psychologists, psychotherapists, psychiatrists, nutritionists, physicians, nurses, and social workers. The major emphasis of the ITA model is on psychological interventions which include individual psychotherapy, family therapy and/or guidance, and group therapy of various formats and contents (e.g., drug abuse, mindfulness, emotion work) tailored to the needs of each patient. However, when required, drugs are prescribed adjusting type of medication and dosage to the need of the patient.

Eligibility Criteria

Age12 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with eating disorders undergoing treatment at "ITA salud mental".

You may qualify if:

  • Diagnosis of an eating disorder: Anorexia Nervosa, Bulimia Nervosa, Binge and other eating disorders Not Otherwise Specified.
  • Treated in one of the centers of "ITA salud mental".

You may not qualify if:

  • Not willing to participate (not signing informed consent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

ITA salud mental-Argentona

Argentona, Catalonia, 08310, Spain

Location

ITA salud mental-Avenir

Barcelona, Catalonia, 08006, Spain

Location

ITA saklud mental-Urgell

Barcelona, Catalonia, 08036, Spain

Location

ITA salud mental-Sabadell

Barcelona, Catalonia, 08202, Spain

Location

ITA saludmental-Tarragona

Tarragona, Catalonia, 43003, Spain

Location

ITA salud mental-Moscatelar

Madrid, 28043, Spain

Location

ITA salud mental-Alcalá

Madrid, 28806, Spain

Location

ITA salud mental-ABB Sevilla Vidrio

Seville, 41003, Spain

Location

Related Publications (1)

  • Grau Tourino A, Feixas G, Medina JC, Paz C, Evans C. Effectiveness of integrated treatment for eating disorders in Spain: protocol for a multicentre, naturalistic, observational study. BMJ Open. 2021 Mar 8;11(3):e043152. doi: 10.1136/bmjopen-2020-043152.

Related Links

MeSH Terms

Conditions

Feeding and Eating DisordersAnorexia NervosaBulimia NervosaBulimia

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersHyperphagia

Study Officials

  • Guillem Feixas, PhD

    Universitat de Barcelona, Spain

    PRINCIPAL INVESTIGATOR
  • Antoni Grau-Touriño, Psychologist

    ITA salud mental, Spain

    STUDY DIRECTOR
  • Chris Evans, MD

    University of Sheffield, UK

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 1, 2019

First Posted

October 15, 2019

Study Start

November 2, 2017

Primary Completion

October 31, 2025

Study Completion

October 31, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations